BioLytical Laboratories


Manufacturer of rapid point-of-care in vitro diagnostic tests focused on infectious diseases. Develops assay platforms in-house, operates an ISO/MDSAP-certified manufacturing facility in Richmond, British Columbia, and distributes diagnostic tests globally for antibody and antigen detection with emphasis on short run-times and low sample volumes.

Industries

Biotechnology
Health Care
Manufacturing
Medical Equipment Manufacturing

Nr. of Employees

medium (51-250)

BioLytical Laboratories


Patents

Methods and rapid test kits facilitating epidemiological surveillance

US-11011278-B1

View Details

Products

INSTI HIV Self Test

Rapid antibody test for personal use designed to provide a visual result in approximately one minute from capillary blood.

INSTI HIV-1/2 Antibody Test (professional)

Professional rapid antibody test for HIV-1 and HIV-2 that provides results in approximately one minute.

Multiplex HIV-1/2 and Syphilis Antibody Test

Rapid multiplex antibody test intended to detect HIV-1/2 and syphilis markers from a single specimen.

Hepatitis C Antibody Test (professional)

Rapid antibody test for hepatitis C intended for professional use with short run-time.

iStatis Hepatitis B Surface Antigen Test

Lateral-flow antigen test for hepatitis B surface antigen intended for professional use with ~15 minute run-time.

iStatis Syphilis Antibody Test

Lateral-flow antibody test for syphilis intended for professional use (≈15 minute run-time).

View All Products

Services

Global sales and distribution of rapid infectious-disease diagnostic test kits for professional and self-use.

Regulatory strategy and quality management experience to support product approvals and ongoing compliance.

Expertise Areas

  • Point-of-care diagnostic development
  • Immunoassay (antibody and antigen) design
  • In-vitro diagnostic manufacturing (ISO/MDSAP)
  • Clinical evaluation and performance validation
  • Show More (4)

Key Technologies

  • Flow-through immunoassay technology
  • Lateral-flow immunoassays
  • Point-of-care diagnostics
  • Multiplex antibody/antigen assays
  • Show More (2)

News & Updates

Company donation of 4,200 rapid HIV self-tests for National HIV Testing Day activities at a retail partner in the USA.

Announcement regarding authorization of a rapid point-of-care hepatitis B test in North America.

Participation of the HIV self-test in a national free distribution program delivering self-tests across the United States.

Products sold in 70 countries and over 35 million people tested using company tests.

Referenced authorization for a rapid hepatitis B test by Health Canada.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.